Mike Biotechnology: Announcement on the repurchase of shares for cancellation and reduction of registered capital and notification to creditors
Securities code: 300463 Securities abbreviation: Mike Biotechnology Announcement number: 2026-047
Mike Biotechnology Co., Ltd.
Announcement on repurchasing shares for cancellation and reduction of registered capital and notifying creditors
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and that there are no false records or misleading
Statements or material omissions.
1. Basic situation of the company repurchasing shares for cancellation and reduction of registered capital
Mike Biotechnology Co., Ltd. (hereinafter referred to as the "Company") held the 10th meeting of the sixth board of directors on June 18, 2026, and held the first extraordinary shareholders' meeting of 2026 on July 6, 2026. The meeting reviewed and approved the "Proposal on the Plan to Repurchase the Company's Shares". The company plans to use its own funds to repurchase some of the company's issued RMB ordinary shares (A shares) in a centralized bidding transaction for cancellation and reduction of registered capital. The total amount of funds to repurchase the shares shall not be less than RMB 50 million and not exceed RMB 100 million (both inclusive). The specific total amount of repurchase funds shall be based on the total amount of funds actually used when the repurchase period expires or the repurchase is completed. Based on the calculation that the upper limit of the share repurchase price is RMB 14.66 per share and the lower limit of the repurchase amount is RMB 50 million, the number of shares to be repurchased is expected to be approximately 3,410,641 shares, accounting for 0.56% of the company's current total share capital; Calculated based on the upper limit of the share repurchase price of RMB 14.66 per share and the upper limit of the repurchase amount of RMB 100 million, the number of shares to be repurchased is expected to be approximately 6,821,282 shares, accounting for 1.13% of the company's current total share capital. The specific number of shares repurchased and its proportion to the company's total share capital shall be subject to the actual number of shares repurchased and its proportion to the company's total share capital. The implementation period for share repurchase is 12 months from the date the company's shareholders meeting approves the repurchase plan. For details, please refer to the "Announcement on the Plan to Repurchase the Company's Shares" (Announcement Number: 2026-040) and the "Report on Share Repurchase" (Announcement Number: 2026-046) disclosed by the company on June 19, 2026, and July 6, 2026 on the cninfo.com.cn. Based on the authorization of the shareholders' meeting, the company will make and implement repurchase decisions based on market conditions during the repurchase period.
2. Relevant information that creditors need to know
After the above-mentioned share repurchase is completed, the cancellation of the repurchased shares will involve a reduction in the company's registered capital. According to the provisions of the "Company Law of the People's Republic of China" and other relevant laws and regulations, the company's creditors have the right to require the company to pay off debts or provide corresponding guarantees with valid creditor's rights documents and relevant certificates within 45 days from the date of disclosure of this announcement. If a creditor fails to exercise the above rights within the prescribed period, it will not affect the validity of its creditor's rights. The relevant debts (obligations) will be transferred to the company according to the original creditor's rights.
Page 1 of 2 Securities code: 300463 Securities abbreviation: Mike Biotechnology Announcement number: 2026-047
The stipulations in the document will continue to be fulfilled.
Creditors can declare on-site, by mail or by email. The specific methods are as follows:
- Declaration time
Within 45 days from July 7, 2026, that is, from July 7, 2026 to August 20, 2026 (working days 9:0012:00, 13:0017:30, excluding weekends and statutory holidays).
- Declaration location and delivery location of application materials
Contact person: Shi Wei Zhang Wenjun
Tel: 028-61619001
Email: [email protected]
Address: Securities Investment Department, Mike Biotech Co., Ltd., No. 1006, Qihuang 1st Road, Shuangliu District, Chengdu City, Sichuan Province
Postal code: 610219
- Information required for debt declaration:
(1) The company's creditors can declare their claims to the company with the originals and copies of contracts, agreements and other documents that prove the existence of a creditor-debt relationship.
(2) If the creditor is a legal person, he must also bring the original and copy of the legal person's business license and the identity document of the legal representative; if he entrusts another person to declare, in addition to the above documents, he must also bring the legal representative's power of attorney and the original and copy of the agent's valid identity document.
(3) If the creditor is a natural person, he must bring the original and a copy of his valid identity document; if he entrusts another person to declare, in addition to the above documents, he must also bring a power of attorney and the original and copy of his agent's valid identity document.
- Other matters:
(1) If declared by mail, the declaration date shall be based on the postmark date, and the words "Declaration of Creditor's Rights" shall be marked on the envelope; (2) If declared by mail, the declaration date shall be based on the date when the document is received by the company's corresponding system, and the title of the email shall be marked with the words "Declaration of Creditor's Rights".
Announcement is hereby made.
Board of Directors of Mike Biotechnology Co., Ltd. July 6, 2026
Page 2 of 2